BUY MRVL → TP $98 +24.2% BUY ALAB → TP $142 +18.7% NEW CBRS coverage just dropped BUY POLYCAB → TP ₹8,450 +11.3% HOLD SMCI → TP $46 −3.1% BUY TRENT → TP ₹6,900 +9.8% BUY IDIA → TP CHF 3.40 +31.5%
🇺🇸 US EQUITY × 🇮🇳 INDIAN EQUITY

Stock research that actually shows its receipts.

Startinv Capital Research publishes institutional-grade research on US AI infrastructure and Indian small & mid-caps — every call comes with a rating, a target price, and a public scoreboard. No vibes-only takes.

40+
Names Covered
120+
Reports Dropped
2
Markets, 1 Standard
🔥 LATEST CALL
INDIA
The Leader for CDMO APIs for New R&D molecules

The Leader for CDMO APIs for New R&D molecules

The Report Library 📚

Initiations, updates, and deep dives — each with a rating, a target, and the full valuation math.

VIEW ALL →
US
Amazon AWS

Amazon AWS Disaggregated Inference strategy with Trainium and Cerebras WSE - 3 chip

Amazon AWS Disaggregated Inference strategy with Trainium and Cerebras WSE - 3 chip

US
Cerebras

Business Understanding of integrated Cerebras WFE wafer for AI inference decode.

US
Marvell Technology

Marvell Technology Present Valuation Report

Marvell Technology Present Valuation Report

US
Marvell Technology

Reports attached

The way Marvell Technology will redefine the Prefill and Decode operations of Inference in AI Inference ramp

INDIA
Neuland Laboratories

The Leader for CDMO APIs for New R&D molecules

The Leader for CDMO APIs for New R&D molecules

INDIA
Zota healthcare - DavaIndia

Democratizing Generic Medicines for every Indian - Zota Healthcare

Democratizing Generic Medicines for every Indian - Zota Healthcare

INDIA
Kernex Microsystem

One of the leaders in KAVACH TCAS System Rollout for Indian Railways

One of the leaders in KAVACH TCAS System Rollout for Indian Railways

INDIA
Indian Railways - KAVACH Anti Collision System Rollout Update

Indian Railways - KAVACH Anti Collision System Rollout Update with Kernex , HBL and Concord control

Indian Railways - KAVACH Anti Collision System Rollout Update with Kernex , HBL and Concord control

INDIA
Beta Drugs and Impact of Cancer Drugs Price Hike

Detailed Report attached

Impact of Indian Govt Cancer Drug Price hike on Indian Onco Focussed companies like Beta Drugs, Sakaar, Natco and Actuaa

Two Desks. One Standard. 🌍

Deep coverage where we have an edge — not a little bit of everything.

🇺🇸 US EQUITY DESK · 14 NAMES

AI Infrastructure & Semis

Custom silicon, advanced packaging, co-packaged optics, power infra, and the data-center supply chain — plus 13F tracking of the funds that move these names.

MRVLALABCBRS SMCIVRTONTOAAOI
🇮🇳 INDIA EQUITY DESK · 9 NAMES

Small & Mid-Cap Compounders

Industrials, consumer, and infrastructure winners of India's capex and formalization cycle — names with real earnings runways.

APL APOLLOTRENTABB INDIA KEIPOLYCABINDIGO TITANJB PHARMA

Pick Your Access 🎟️

One report, the whole library, or your own research desk on call.

Single Report

One-off due diligence
$29 / report
  • Full PDF research note
  • Valuation framework + scenarios
  • Charts & data appendix
  • Yours forever
Browse Reports
✦ MOST POPULAR ✦

Member

For active investors
$49 / month
  • Full library — US + India desks
  • Every new initiation & update
  • Live call alerts on WhatsApp 💬
  • 13F & thematic study decks
  • Scoreboard dashboard access
Start Membership →

Institutional

Funds & family offices
Custom
  • Bespoke coverage requests
  • Analyst access + model files
  • White-label research options
  • Multi-seat licensing
Talk to the Desk